Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

133
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
133
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

114
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
114
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

95
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
95
Obesity01:24

Obesity

999
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
999
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

6.0K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.0K
Variability: Analysis01:11

Variability: Analysis

343
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
343

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced CARS2 expression elicits a low-grade pro-inflammatory signature in THP-1 macrophages.

Frontiers in immunology·2026
Same author

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Atherosclerosis·2026
Same author

Genetics and Genomics of Coronary Artery Disease: What We Have Learned.

The Canadian journal of cardiology·2026
Same author

Functional and metabolomic analyses of brown adipose tissue during cold-deacclimation reveal rapid N-acetylated amino acid adaptations.

iScience·2026
Same author

Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines.

FEBS open bio·2026
Same author

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

JACC. Advances·2026

Related Experiment Video

Updated: Dec 6, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

726

Factors affecting weight loss variability in obesity.

Robert Dent1, Ruth McPherson2, Mary-Ellen Harper3

  • 1Department of Medicine, Division of Endocrinology and The Ottawa Hospital, University of Ottawa, 210 Melrose Ave, Ottawa, ON K1Y 4K7, Canada.

Metabolism: Clinical and Experimental
|October 9, 2020
PubMed
Summary

Individual weight loss results vary significantly despite current obesity treatments. Research highlights that genetics, neurohormonal responses, and metabolism contribute to these differences, paving the way for personalized obesity therapies.

Keywords:
Bariatric surgeryEnergy expenditureGenetic predictors of obesityHypocaloric dietsInterindividual variabilityObesityThermogenesisWeight lossWeight loss medications

More Related Videos

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

204

Related Experiment Videos

Last Updated: Dec 6, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

726
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

204

Area of Science:

  • Obesity Research
  • Metabolic Science
  • Personalized Medicine

Background:

  • Current obesity treatments (diet, exercise, surgery, medication) show highly variable individual weight loss outcomes.
  • While factors like adherence, age, sex, and medication are recognized, significant variability persists.
  • Understanding these differences is crucial for advancing obesity management.

Purpose of the Study:

  • To review research on factors contributing to inter-individual variability in obesity treatment response.
  • To identify known and potential underlying mechanisms driving differential weight loss.
  • To emphasize the need for personalized approaches in obesity therapy.

Main Methods:

  • Systematic review of human studies on obesity treatment response.
  • Analysis of factors influencing weight loss capacity across different interventions.
  • Exploration of genetic, neurohormonal, metabolic, and microbiome influences.

Main Results:

  • Diet adherence, physical activity, sex, age, and medications are established factors influencing weight loss.
  • Even after controlling for these, significant inter-individual differences in weight loss remain.
  • Complex feedback mechanisms, genetic factors, neurohormonal signaling, metabolic efficiency, and gut microbiome play roles.

Conclusions:

  • Inter-individual variability in obesity treatment response is multifactorial.
  • Poorly defined genetic and differential neurohormonal/metabolic responses are key contributors.
  • A deeper understanding will enable personalized obesity treatment strategies.